current user: public

If you have questions about the server, please let us know.

Query: [P] KOG4505 Na+/H+ antiporter, from VFDB

Results of FFAS03 search in VFDB
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520    .  530    .  540    .  550    .  560    .  570    .  580    .  590    .  600    .  610    .  620    .  630    .  640    .  650    .  660    .  670    .  680    .  690    .  700    .  710    .  720    .  730    .  740    .  750    .
# Score Template Links and tools%idFirst MAWSQVEISKPHLAYAIIGGFTSLFMLCSLIIKEKLFLGEATMATATGLIFGPYVAKLFVPTSWGNTDYITEELARVLLVVEVFAAGAELPRAYMLRHWRSMFVMLLPVMIFGWLVSTGFMYALIPRLSFLESLAIAACITATDPVLASSIVGKGKFARRVPGHLRNMLLAESGCNDGMAIPFLYLAIYLIIEKPARHAGRDWVCIIILYECTFGCVLGAIIGVIARKMIKFSERRGLMDRESFLVFYFVLALFCGGIGTIIGVDDLLVSFCAGAAFSWDSWFSKKTEESHVSNVIDLLLNLSFFVYVGAIMPWPQFHMPHMDLSVWRLVVLAICILIARRIPAVLLFKSFVPDIINWREALFAGHFGPIGVGALYTCLVARAELEVHSTVPEPNDAIENPEIPNWYCIQVMWPVVCFLVLSSIIVHGSSIAFFMLGKRINTLALSFTRTRDSHFAFNLPRVRQGQSLPIKRVDALRSSANSIASSIRRRHPVNIQEDEDADISTVSLPEAAHLREERAESPRGGHYDAEEFPSEDYESRQPRRSNEEDREEEMNPGDETYLIGEDLVVEDSQGNIISHTSSRDANGPSIDEKLAQGDPKAKSFGRKFRSFLRRSYDTFQRNLHEPDDERQREPTLGHIESSIENHRPRYSRQNSESHLRENSVERRRREQVLTNIGDSESEDDNIPRPGIVPFYNENNESSSDTRNGLLSDNVSESRSRRPSRAPSAAVSSEGSPVEEDNEAQHRPNIRFLELTRAWELast
1 -130.000[P] KOG4505 Na+/H+ antiporter  ali  100  1MAWSQVEISKPHLAYAIIGGFTSLFMLCSLIIKEKLFLGEATMATATGLIFGPYVAKLFVPTSWGNTDYITEELARVLLVVEVFAAGAELPRAYMLRHWRSMFVMLLPVMIFGWLVSTGFMYALIPRLSFLESLAIAACITATDPVLASSIVGKGKFARRVPGHLRNMLLAESGCNDGMAIPFLYLAIYLIIEKPARHAGRDWVCIIILYECTFGCVLGAIIGVIARKMIKFSERRGLMDRESFLVFYFVLALFCGGIGTIIGVDDLLVSFCAGAAFSWDSWFSKKTEESHVSNVIDLLLNLSFFVYVGAIMPWPQFHMPHMDLSVWRLVVLAICILIARRIPAVLLFKSFVPDIINWREALFAGHFGPIGVGALYTCLVARAELEVHSTVPEPNDAIENPEIPNWYCIQVMWPVVCFLVLSSIIVHGSSIAFFMLGKRINTLALSFTRTRDSHFAFNLPRVRQGQSLPIKRVDALRSSANSIASSIRRRHPVNIQEDEDADISTVSLPEAAHLREERAESPRGGHYDAEEFPSEDYESRQPRRSNEEDREEEMNPGDETYLIGEDLVVEDSQGNIISHTSSRDANGPSIDEKLAQGDPKAKSFGRKFRSFLRRSYDTFQRNLHEPDDERQREPTLGHIESSIENHRPRYSRQNSESHLRENSVERRRREQVLTNIGDSESEDDNIPRPGIVPFYNENNESSSDTRNGLLSDNVSESRSRRPSRAPSAAVSSEGSPVEEDNEAQHRPNIRFLELTRAWE 759
2 -56.900[P] COG3263 NhaP-type Na+/H+ and K+/H+ antiporters with a unique C-terminal domain  ali follow..  15  1................................................MLAGVDGVGGIPFD----NYPFAYMVSNLALAIILLDGGMRTQASSFRVALGPALSLATLGVLITSGLTGMMAAWLF-NLDLIEGLLIGAIVGSTDAAAVFSLLG----GKGLNERVGSTLEIESGSNDPMAVFLTITLIAMIQHHESNISWM--FIVDILQQFGLGIVIGLGGGYLLLQMINRIA----LPAGLYPLLALSGGILIFSLTTALEGSGILAVYLCGFLLGNRPIRNRYG-ILQNFDGLAWLAQIAMFLVLGLLVNPSDLLP----IAIPALILSAWMIFFARPLSVFAGLLPF--RGFNLRERVFISWVGLRGAVPIILAVFPMM--------------------AGLENARLFFNVAFFVVLVSLLLQGTSLSWAAKKAKVVVPPVG......................................................................................................................................................................................................................................................................................................................... 356
3 -52.000[P] COG0025 NhaP-type Na+/H+ and K+/H+ antiporters  ali follow..  14  2.........EIFFTILILILVVSLSGVVTRMLPFQ--VPLPLMQIVCGALLA--------PNFGLHVNFDPELFLVLFIPPLLFADGWKTPTREFIHHGREILGLALALVLVTIVGIGYLIYWMVPGIPLVAAFALAAVLSPTDAVALSGIVG----KGRIPKSIMGVLEGEALMNDASGLVALKFAIAVAMGTMIFTVSG--ATLEFLKVAIGGLLAGVAITWLYSKSLRIMSRWSGDDPATQIVLLLLLPFASYLVAEHLGVSGILAAVAAGMTISQSGPLAMRLRADSVWSMLEFVFNGMVFILLGLQLP-ELDPTIQTWNLFADVAIIYGALLLLRFGWLWSMKRPLQFSDYTTRELWVASFAGVRGAITLAGVLSIPLFLSDGSA---------------FPSRYQLVFIATGVILLSVIIGVIALPPLLRGVVVADKSASREEIRLARAAMAEVAIVSLNKMEERLMTSSEENIDSELLKEVSSRVIGTLRRRTGSKDEVENTLLIENLERRFRLTALRAERGELYHLRATQKISNETLQKLLHDLDLLEALLIEKEG................................................................................................................................................................................................... 549
4 -51.600[P] KOG1966 Sodium/hydrogen exchanger protein  ali follow..  10  14WNWDHIHKVYVITTWLLVASLAKILFNLMKPLSKW--LPDSSLLIIVGLGLG-----FLNQTTLSGVHLDSHAFFLYLLPPIIFDAGYFMPNRALFKNFDSVLVFSVLGTLWNTFAIGGSLLIMSKPFTTFEILVFSALISAVDPVAVIAIFE----EIHVNEFLFINVFGEALFNDGVTVVLYQMFKSFALIGSENLSPWDYAGLSFFVVALGGAAIGIIFAIATSLATKYTQG----IKILAPVFIFLLPYMAYLTAEMVSLSSIIAIAVCGMLMKQYIKGNATNSVKYFTKMLAQCSETVIFMFLGLSTLTSEHH-----VDFIFIGATLVFCLIYRAIGIIVQLNKFRAKKFEVVDQFILSYGGLRGAIAYGLVVSIPASIQ---------------------AKPMFITTTICVIYFTVFLQGITIRPLVNCLNVKKKEHREATMVESVYNKYLDYMMSGVEDIAGQRGHYSFIENFERFNAKVIKPVLMRHEKRQSFDATSIIRAYEKITLEDAIKLTKVKSTLQNKRLEKVKSEVRVAPEQTTVTPKDVQLARFMQSGENIDQLYTLFSDLLDKKLNELKVQADKVDKANDDDIQDDYMAEMGSHSNLGFMHHSADQLDSDSVFQRRGRRLSTGDLKGHCGTSRKPKHSMFELRH................................................................................................. 650
5 -47.500[P] KOG1965 Sodium/hydrogen exchanger protein  ali follow..  14  24............VSMNLFVALLCACIVLGHLLEETRWMNESITALIIGSCTGIVILLISGGKSSRILVFSEDLFFIYLLPPIIFNAGFQVKKKQFFRNFMTIMLFGAIGTLISFVIISFGAKHLFEDLTIADYLAIGAIFSATDSVCTLQVLNQDETPL-----LYSLVFGEGVVNDATSVVLFNAIQRFDLTNINSAIALE-FAGNFFYLFILSTALGVAAGLLSAFVIKKLYIGR--STDREVALMMLLAYLSYMLAELFHLSSILTVFFCGIVMSHYTWHNSKVTTKHTFAAMSFLAEIFIFLYVGMDALDIEVVRNSPGQSIGVSSILLGLILLGRAAFVFPLSFLSDEKIDLKKQVTIWWAGLMRGAVSMALAYNQFTTSGHTKVL----------------GNAIMITSTITVVLFSTVVFGLLTKPLVKHLQPSSKQSSTTALQIT.................................................................................................................................................................................................................................................................................................................. 460
6 -42.600[P] KOG3826 Na+/H+ antiporter  ali follow..  12  67..............SIFVIFILLVAGIFAAKISKALRLPPLFGCLALGIIIKNITVFDQFFVF---PPFVETMIRKVALVMIIVRWGLATDIHFLYENALMPVTIGLVTAIGEIIAVTIASYFIL-NISFVMSIFCALILVTVSPAVTVPAMINKEKQLGSLKRIPENILAICCVDNLFCVILFMVLSSIIFTDAPIATT----ILLNAGSIVFGCIGGIVLGWILWRFPRSDAPH-TQFARITLLGTICIAVVIGTYLIKYSCSGFLAALITSAMSAMDNKEKLECVESTYKYIWDSFALPLLFICLGMKFDCSTLTWEIVFL----CIAVIAIGLLVRTILVMLVTL---SSHINFKEQIVVALS-PRATFQADLAPTLLL--------------MATPFPDMAKDAALILKAAILSVLITAPIFDILLNLVGSKCLSQYNPQDAPAIEKNFDKTY............................................................................................................................................................................................................................................................................................................. 486
7 -24.800[P] COG0475 Kef-type K+ transport systems, membrane components  ali follow..  14  1..........MNDHILINVIILLGTAVFIVAILKRFRLSPVLGYLIAGAAIGDHGLKIVTYDQ-------TKLLGELGVVFLLFAIGLELSFERLKAMRRYVFGLGSLQVLTTAIVIAGAMVLI--DGNSSAAIITGGGLALSSTALVMQVIDENRSQSTQIGRISLAILL---LQDLAVVPLLVIVPLLASNNKASLAV---ALGIAFLKAVTALLTIFIVGVLLRPVFSFISSESNNTSELPISMTLLIVLSAAWATETFGLSLALGAFVAGVLVAETEF---RLQAEESIYPFKSLFLGLFFMTVGMNIDALEMYE-----KISHILTLSIALICIKTLIITAFCILF---GFNKGVAFYSG-LSQGGEFGFILFSLGKDS----------------------VLEESTADILLLVVTFTMAL............................................................................................................................................................................................................................................................................................................................................. 371
8 -24.600[P] COG4651 Kef-type K+ transport system, predicted NAD-binding component  ali follow..  15  7..............LITTIVGGLVLAFILGMLANKLRISPLVGYLLAGVLAGPFTPGFVA------DTKLAPELAELGVILLMFGVGLHFSLKDLMAVKAIAIPGAIAQIAVATLLGMALSAVL--GWSLMTGIVFGLCLSTASTVVLLRALEERQLIDSQRGQIAIGWLI---VEDLVMVLTLVLLPAVAGMMEQGDVGFATLAVDMGITIGKVIAFIAIMMLVGRRLVPWIMARSAATGSRELFTLSVLALIAFGAVELFDVSFALGAFFAGMVLNESEL---SHRAAHDTLPLRDAFAVLFFVSVGMLFDPLILIQ-----QPLAVLATLAIILFGKSLAAFFLVRLF---GHSQRTALTIA-LAQIGEFAFILAGLGMAL----------------------LLPQAGQNLVLAGAILSIML............................................................................................................................................................................................................................................................................................................................................. 379
9 -23.300[P] KOG1650 Predicted K+/H+-antiporter  ali follow..  52.............LMLLQMSVIIITSRLLYRLLKPLKQGMISAQVLAGIILGPSLFGQSS----ISGKITLQTLSNLGFFIHLFLLGLRIDASIIRKAGSKAILIGTASYALPFSLGNLTVLFLKNTYN-HCISTVISLNAMT----SFPVTTTVLAELNINSDLGRLATNCSIVCEAFSWIVALVFRMFLRDGTLAS------VWSFVWVTALILVIFFVCRPAIIWLTERRSISIDKAGEIPFFPIIMVLLTISLTSEVLGVHAAFGAFWLGVSLPDGPPLGT-GLTTKLEMFATSLMLPCFISISGLQTNFFIIGESHVKIIEAVILITYGCKFLGTAAASAYC-------NIQIGDAFSLALMCCQGVIEIYTCVMWKDEKVLNTE------------------------CFNLLIITLLLVTGISRFLVVCLYDPSKRYRSKSKRTI................................................................................................................................................................................................................................................................................................................... 459
10 -14.400[R] KOG2140 Uncharacterized conserved protein  ali follow..  171...NKVNISNISIIIQELLQENIVRGLLSRSVLQAQSASPIFTHVYAALVA----------------NSKFPQIGELILKRLIFRKGYRRNDKQLCLTASKFVAHLINQNVAHEVLCLEMLTLLLESVEVAIGFLCGLKLTQVSPRGINAILRNILHESEIDKRVQYMIE---------------VMFAVRKDGFKDHPIILEGLDLVEED-------------------DQFTHMLPLEDDYNPEDVLNVFKMDPNFMENEEKYKAIKKEILDEGDTDSNTDQDAGSSEE-TEINLVSFRRTIYLAIQSSLDFEECAHKLLKMEFPESQTKELCNMILD------------------QQRTYEKFFGLLA--MESFEGIFKEQYDTIHRLETNKLRNVAKMFAHLLYTDSLLECIKLSEETTTSSSRIFVKIFFQELCEYMGLPKLNARLKDETLQPFFEGLLPRDNPRNTRFAINFFTSIGLGGLTDELREHLKNTPKVIVAQKPDVEQNKSSPSSSSSASSSSESDSSDSDSDSSDSSSESSSEESDSSSISSHSSASANDVRKKGHGKTRSKEVDKLIRNQQTNDRKQKERRQEHGHQETRTERERRSEKHRDQNSSGSNWRDPITKYTSDKDVPSERNNYSRVANDRDQEMHIDLENKHGDPKKKRGERRNSFSENEKHTHRIKDSENFRRKDRSKSKEMNRKHSGSRSDEDRYQNGAERRWEKSSRYSEQSRESKKNQDRRREKSPAKQK... 908
11 -13.500[R] COG0385 Predicted Na+-dependent transporter  ali follow..  12  2..................................RFLPDKFTTMLIATILFA------SVLPVRGEFAVWFALATKIAVGLLFFLHGARLSREAVIAGITHW-KLHVTVLASTFVLFPILGLAAAIPGLSQSPFYTGILYLCVLPTVQSSIAFTSMARGNVSAAV-----VSASASNIFGMFLTPLLVGLLFAIKGGGGISMDALESILLQLLAPFVLGQVLQPFIGNFVRRKARVLAVVDRGSILMVVYLAFMMVGVNILLLAVVLLATWYGSKWLGFSRPDRITIMFCGSKKSLA----------SGALMANAIFAGANVGNIVLPLMLFHQIQLMACAIIA............................................................................................................................................................................................................................................................................................................................................................................................................................... 310
12 -13.200[A] KOG2217 U4/U6.U5 snRNP associated protein  ali follow..  5..................................................................................................................................................................................................................................................................................................................................................................................................................................................SSGKKHKKDKKNRHRSRSSERPRRVTEDEDVTLDLTDDSSSRHRHHKHKKHKEHRHKHHKQKERERANEVISLEESDSDSSDCVEVPVQAQVQAQAKLRDARESSNRDKERDSGRDRELLRERERERDRERERDRDREKEREREREKERLREREEREREREKERIREREKERLRERERERERERVRELTAPPPPQISKHAEYESRREREIERERDARKRSGRERERERNRERSRSQSPASSSRKPATKEREPSSRSFSPIPENGAGDVLSITETNKLRAKLGLKPLEVDSGPSKAGPPPGSSSQGEIKKPHGEADLSSYKDEWGE 329
13 -13.000[R] KOG4821 Predicted Na+-dependent cotransporter  ali follow..  16...........................VTEFLKSQWFFICLAILIVIARFAPNFA-------RDGGLIKGQYSIGYGCVAWIFLQSGLGMKSRSLMANMLN--RAHATILVLSFLITSSIVYGFCCAVKIDDWVLIGLILTATCPTVASNVIMTTNAGGNSLLCV-----CEVFIGNLLGAFITPALVQMFTNRAPFAYGNPATYGRVMKQVGLSVFVPLFVGQVIQNCFPKGTAYGFLKKYHIKIGSYMLLLIMFSSFSTAFYQDAFTSVSHVCII------------------------FLCFFNLGIYIFFTGLSYLCARPWFILKLFPHEPIEGKSTRLYRYSYNIFRPFYYSKEDAICIMFCGPAKTAALGVSLITSQYGDKKEH-----------------LGKLLVPLVLY--VEQVMTANFFVSLFKRWIQKDAQADGSESSCANENEEVDLEKIISIGTGENQSVLSNNVPYTQPR.................................................................................................................................................................................................................................................................................. 434
14 -12.900[Z] KOG3756 Pinin (desmosome-associated protein)  ali follow..  400.........................................................................................................................................................................................................................................................................................................................................................................................................................................................IADQEVMETNRVESVEPSENEASKELEPEMEFEIEPDKECKTLSPGKENVSALDMEKESEEKEEKESEPQPEPVAQPQPQSQPQLQLQSQSQPVLQSQPPSQPEDLSLAVLQPTPQVTQEQGHLLPERKDFPVESVKLTEVPVEPVLTVHPESKSKTKTRSRSRGRARNKTSKSRSRSSSSSSSSSSSTSSSSGSSSSSGSSSSRSSSSSSSSTSGSSSRDSSSSTSSSSESRSRSRGRGHNRDRKHRRSVDRKRRDTSGLERSHKSSKGGSSRDTKGSKDKNSRSDRKRSISESSRSGKRSSRSERDRKSDRKDKRR 717
15 -12.900[R] KOG2295 C2H2 Zn-finger protein  ali follow..  245.....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DSSQADALIRVLDTCVIKLEGGTDEDLKVLDEKPKDPVVYERKAEQMQSVKEVEKTINSPKEEMSEADPVSTQRKPVRPVNSDGENWDDDDAENSAPKKELAEDSKDSDSKPEDKQLNKKKTKKRKRNSSDDDSSSSESSSSSDEEKLKEKYDVEDGLRAEQKTEAEKDRQEATKAKQGPQSPKLDEDEGNENTEPKGLDSKINTYEEIDNTLKSPEISSNPIKNTDNGDGSKVEEDGEKPSVGKDKVVETETIDLDKVKDGQPRALHRTSS.. 516
16 -12.800[A] KOG4676 Splicing factor, arginine/serine-rich  ali follow..  167.........................................................................................................................................................................................................................................................................................................................................................................................................................................................LAALGLPGANLNSQSLAADQLLKLMSTVDPKLNHVAAGLVSPSLKSDTSSKEIEEAMKRVREAQSLISAAIEPDKKEEKRRHSRSRSRSRRRRTPSSSRHRRSRSRSRRRSHSKSRSRRRSKSPRRRRSHSRERGRRSRSTSKTRDKKKEDKEKKRSKTPPKSYSTARRSRSASRERRRRRSRSGTRSPKKPRSPKRKLSRSPSPRRHKKEKKKDKDKERSRDERERSTSKKKKSKDKEKDRERKSESDKDVKQVTRDYDEEEQGYDSEKEKKEEKKPIETGSPKTKECSVEKGTGDSLRESKVNGDDHHEEDMDMSD 484
17 -12.700[S] KOG4051 Uncharacterized conserved protein  ali follow..  138.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ENARKSPNSNEEYPRVEDMNEKDSTIPKESPSTDLKNDNNKQEKNATIKVKELPEYHTEENDSPIDVQKEPIKEVQSDEKELQREHMSEEEQKMKSTNKTAAPVRKSQRLKRSKEVKFEDEEKEEIEEDNTKDEEQKEKKEEIQEPKITHNEEVDKEKNENEEGDDEREKSTSYENTNGSESEGVDEGVDEELGYESEREAEGKGKQIESEGGNLKKKTENKKGDDQQDDTKKDSKDKNEPLAKRTRHSSSTGNTSNETSPKRKRRKAGSRKNSPPATRVSSRLRNKK 425
18 -12.300[K] KOG3794 CBF1-interacting corepressor CIR and related proteins  ali follow..  320.........................................................................................................................................................................................................................................................................................................................................................................................................................................................EILKSMSSDKKRKSKKNKRHKKHSSRTVEETDESSTGSEDSREKRGSKKRKKLKKKSKKQYDSDSLSFEGSGSDSYRLSRRRHTKHVDPSASLKSEVYHQGNSHREKHYYDEKHQKRKEIVDRPSASSDDSDYYRSNSSRKKRSEDDYKSHHRERKQVHSNDPVSEKSQKQHYSESGKIQRVEKEHRYDERRHRYVDMESENRNRSEKKPRYDDRDSEKHHRSVKGKEKHVYEASDDPEEFSDRYRSTKKTESDSESNRRSRKKKHELSSEEEEGESRVIGEQVRKSMSLIHRRLYRISGLSSVNAWNLQIREAVNRN 637
19 -12.300[S] COG2855 Predicted membrane protein  ali follow..  12  21...................ALSAVITGVALWGGSGAGFSALTLAILLGMVLG----NTIYPHIWKSCDGGVLFAKQYLLRLGIILYGFRLTFSQIADVGISGIIIDVLTLSSTFLLACFLGQKVF-GLDKHTSWLIGSICGAAAVLATEPVVKAEASKVTVAVATVVIFGTVA-----FLYPAIYPLMSQWFSPETFGIYIGSTVHEVAQVVAAGHAISPDAENAAV-ISKMLR--------VMMLAPFLILLAARVKQLSGANSGFAILFIVVAIFNSFHLLPQS--VVNMLVTLDTFLLAMAMAALGLTTHVSALKKAGAKPLLMALVLFAWLIVGGGAINYVI............................................................................................................................................................................................................................................................................................................................................................................................................................. 344
20 -12.300[R] KOG4264 Nucleo-cytoplasmic protein MLN51  ali follow..  4........................................................................................................................................................................................................................................................................................................................................................................................................................................................................RRRQRASQDTEDEESGASGSDSGGSPLRGGGSCSGSAGGGGSGSLPSQRGGRTGALHLRRVESGGAKSAEESECESEDGIEGDAVLSDYESAEDSEGEEGEYSEEENSKVELKSEANDAVNSSTKEEKGEEKPDTKSTVTGERQSGDGQESTEPVENKVGKKGPKHLDDDEDRKNPAYIPRKGLFFEHDLRGQTQEEEVRPKGRQRKLWKDEGRWEHDKFREDEQSRQELIALYGYDIRSAHNPDDIKPRRIRKPRYGSPPQRDPNWNGERLNKSHRHQGLGGTLPPRTFINRNAAGTGRMSA 309
21 -12.200[P] KOG2718 Na+-bile acid cotransporter  ali follow..  11  103..........................................IWVSLGCLLGLMRPSTFN---------VTPNWTIVGLTITMLGMGMTLTLDDLRGALSMPKELF-AGFLLQYSVMPLSAFFVSKLLNLPPHYAAGLILVGCCPGGTASNIVTYIARGNVA--LSVLMTAASTV---SAVIMTPLLTAKLAKQYITVDALG-LLMSTLQVVLLPVLAGAFLNQYFKKLVKFVSPVMPPIAVGTVAILCGYAIGVVLASCLLHISGFLFGYLFSRILGIDVASSRTISIEVGMQNSV----------LGVVLATQHFGNPLTAVP--CAVSSVCHSILGSVLAGIW............................................................................................................................................................................................................................................................................................................................................................................................................................. 391
22 -11.900[B] KOG2266 Chromatin-associated protein Dek and related proteins, contains SAP DNA binding domain  ali follow..  2.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................GEDTKATIEPTANKTTSLEKPSEAMAGKENAGGKETQELAKDEDMAEPDNMEIDAQIKKDDEKAETEDKESEVKKNEDNAETQKMEEKVEVTKDEGQAEATNMDEDADGKKEQTDDGVSVEDTVMKENVESKDNNYAKDDEKETKETDITEADHKKAGKEDIQHEADKANGTKDGNTGDIKEEGTLVDEDKGTDMDEKVENGDENKQVENVEGKEKEDKEENKTKEVEAAKAEVDESKVEDEKEGSEDENDNEKVESKDAKEDEKEETNDDKEDEKEESKGSKKRGKGTSSGGKVREKNKTE 303
23 -11.900[R] KOG3263 Nucleic acid binding protein  ali follow..  2.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SSSRSGEHRRNYAQGRNYESSRSRGDQRDRDYREYRRNYRDERSSRRYEDSQRRDYSPARRRDRYERHRESVREESPRRPVEHERNWQPELKHGRERFRERDYEGRRDRKERRDGVSPFSPEGEGLERKREHEKLQAPSPKEEEERPVDQGDKMDGVKEDKDGSLEVGKSHDAMTRTKSAEEEIVEQEDEATAEMKRIMGFSGFDTTTGKKHGDVGQVYKQKKTKYRQY. 230
24 -11.900[DZ] KOG2229 Protein required for actin cytoskeleton organization and cell cycle progression  ali follow..  112..............................................................................LKQLLLEHHKSLPFELKEKILSCLTMLRNKDVITAEELIQSLFPLLVAYSSHGNSLGVNSHAKELRKIIYTNLISLNGKNQKLNKSTQAVCFNLLDQPDSQGIWATKLTRELWRRGIWDDSRTVEIMTQAALHQDVKIVMSGVMFFLDAD--REREENFEENSEDEDGFDLDALRHKMQVNKKTGRRGKKLENAIKTVKKKKKNGPGAPQGYLNFSAIHLLRDPQGFALFKEHLSGKTKNKFDMEQ-------ISLMQLLSRLI-------------------------GTHKLIVLGIYTFFLKYLTPKQRDVTRIMSACAQACHDLVPPEVINVMVR-KIADEFVSDGVANEVAAAGINTIREICSRAPLAIDEILLQDLVEYKGSKAKGVNMAAKSLIALYRDVAPEMLKKKDRGKNAAMEVQEAKKGGKDSKRPQFGADNSVQGIAGIELLAKWKKEHGEESENEDADANWEVDVDSEEDDVDGEWVTMDSDKEYDVDMEDSDDEKDNAKGKESDSDLELSDDDDEKEVKDEQEDADIDPEAAFREIASTRILTPADFAKLQELRNEESVAKIMGIHKQDKREELVDASTLTGPIKYKQSREERLQKVLEGREGRDKFGSRRGKRDNMRSTTNREKERRKNFVMSIHKRSVRGKQKMSLRDKQKVLRAHITKQKKKG 766
25 -11.800[S] KOG3869 Uncharacterized conserved protein  ali follow..  194........................................................................................................................................................................................................................................................................................................................................................................................................................................................AEGKKKNKKNKKSKKSKKKKKNRRSSNEESSDSESNDSDDDLDRKLARQVSKLKGDQGDLKLDKLLDAKYRTISNQLDMATKKKKSKKSKKKKSSDSSDESSDEEEEPRRKHKRSHSSEDRNQRERRRSRSPRDRKKRQSRSPEQRQRQRSPEERRERRRSRSRSPLARRQRRTRSPEDRKARRQSKDTSKQREKRRSRTPEERSRSKRSRSRSSKGDDKRRIAERPPPSRPTGKPKLSEADREARLREMMDNATWREADRSQVVRKHREAYAREEAQNRERDFDKEFINKEVKKAIANHNSIGDRIRANLNNIQRTAS 512
26 -11.700[A] KOG2548 SWAP mRNA splicing regulator  ali follow..  10  596......................................................................................................................................................................................................................................................................................................................................................................................................................................................ARMLNVNQALTATAPVAVQPQVVEPPPPPLKRYYGRKRGNDTSSSSSSGAENSEGSDNEEQQQPQLGKRAEDSDDMELDTASERSHALQPTMSSSSSTGNQTGKYSSATETGSGHPSSGGGGRPNLRERLKRKMQNLLNRQYKADKRAEIEKTERERLQQQEREDEMRELALKLRRRRRELRHKYGTPSSGKLSDSDAESVASESQLAKSSTRRSRSRSESRRRSPPPETQHSRRSSSRTERRRRTRTPSPKYNRRQRSRSRSGSRVERKRRSHSRRRSGSRDRRRSRSRRSQSRRRRQRDRSIERNREREQYRQQHQQQN 916
27 -11.600[S] KOG2465 Uncharacterized conserved protein  ali follow..  113.............................................................................................................................PDVDWEETVYLNMVIHQFDYTLTLAICTRTSPKRRHSQRVRRKMDTKG--GEEITYPHICFMVD--------------------------------------------------DEVFSDILVRDGEMVCVELVANDKDGAVQGVIFLGSIRYDALKKVYDARQSSLSSKVAQRMSFGLFSSGA-----------------------------------------------VQTRCEFVRMKGPKGHAEMAVTKPKGSGVETPTSEPGFCATDMWDEWEEENDDYCTYRHQRRLSDPSANLNNFSRYGWRTKNSNNQDMVGSGTSPSVGAKARSENEGASEVSEIEAGDLRDDQQRPAFSASAAKLHPNPNCETHKLATGDQEKLTQESPRESTSSAPAEVAVPAVTPPPLSAAVEVTVSGDVSVTGHSSTTGCNCFGGKKCKKRWASAKNTDTPEMSEVYCPSCEDPSNESPACLAKMPDKRPTRLKPKSSILSVESELLVGKRSSFRLPSEIKRKQQGGSITRSASLSAADRRTSLPVATKRIIPPRLRTAKAKDLEKDKEKEKDKNKENDKKSSNQKVNGSATNFLAKMSPKRLKAGKEKDKDKDGNKEKEKDKFKAMDAAKKKAVNNNNP 667
28 -11.500[P] COG0798 Arsenite efflux pump ACR3 and related permeases  ali follow..  15.................................EKYLTLWVFLCIFVGIALGRLFPELAVKLDAISVYQVSIPIA-VCLFFMMYPIMVKIDFTQAMNALRTP-KPVILTLVVNWLIKPFTMVAFGGEVAIANSYIAGTILLGIAPCTAMVLMWGYLSYGNQGHTLVMVA-----VNSLAMLFLYAPLGRWLLAANDLTVPWQTIVLSVLIYVGLPLIAGIYSRYW---IFKYKGKEWFESRFLKYLSPIAITALLLTLILLFAFKG-------------------ELIVKNPLHILLIAVPLFIQTNFIFLISYVAALKLNLAYE----AAPAALIGASNHFEVAIATA--------------VMLFGLNSGAALATVVGVLIEVP..................................................................................................................................................................................................................................................................................................................................................................................... 341
29 -11.400[E] COG0786 Na+/glutamate symporter  ali follow..  10  8.........GALESFLIAISVLFLGHFINAKLPTKFNIPEPIVGGLIVACVITAL------HFHGIDMEFSLPLQNVFMLMFFSTVGLAANYTQLIKGGAKVFLFLAVASVFIIIGVGVSLAAGL-GLDPLLGLIAGSI----------TLSGGHGTGAAWANTFAENYGLANTLEIAMASATF------------------------------GLIIGGIIG-VAQKLVDKHGIESEYGRGTQVIEILFILLICVTGAKYLEA--FVYALFIGVFITNLLEVTKLRKVDA--ETVDILGTVSLSLFLAMAL--MSLKLWNIFDLALPFLVILAIQSVVLGVFCYFVTFKVMGANYD-AAVISAGHCG--GLGATPTAVMNMGSVVKRFGPSPQAFMVVPIVGAFFIDIVNLIILQGYISFLG................................................................................................................................................................................................................................................................................................................................................ 408
30 -11.400[P] COG3004 Na+/H+ antiporter  ali follow..  13  14..................GGIILIIAAILAMIMANSGATSGWYHDFLETPVQ------LRVGSLEINKNMLLWINDALMAVFFLLVGLEVKRELMQGSLASLRQAAFPVIAAIGGMIVPALLYLAFNYADPITREGWAIPAATDIAFALGVLA---LGSRVPLALKIFLMALAIIDDLGAIIIIALF--------------------YTNDLSMASLGVAAVAIAVLAVLNLCGARRT-------GVYILVGVVLWTAVLKSGVHATLAGVIVGFFIPLKEK-HGRSPAKRLEHVLHPWVAYLILPLFAFANAGVSLQGVTLDGLTSILPLIIAGLLIGKPLGISLFCLAHLPEGTTYQQIMVVGILCGIGTMSIFIASLAFGS---------VDPELINWAKLGILVGSISSAVIGYSWL.................................................................................................................................................................................................................................................................................................................................................. 380
31 -11.400[K] KOG2821 RNA polymerase II transcription elongation factor Elongin/SIII, subunit elongin A  ali follow..  28.........................................................................................................................................................................................................................................................................................................................................................................................................................KYLKKLSTLPITVDILAEGKTVNSLRKHEHVGSFARDLVAQWKKLVPVERNAEPDEQDFEKSNSRKRPRDALQKEEEMEGDYQETWKATGSRSYSPDHRQKKHRKLSELERPHKVSHGHERRDERKRCHRMSPTYSSDPESSDYGHVQSPPSCTSPHQMYVDHYRSLEEDQEPIVSHQKPGKGHSNAFQDRLGASQERHLGEPHGKGVVSQNKEHKSSHKDKRPVDAKSDEKASVVSREKSHKALSKEENRRPPSGDNAREKPPSSGVKKEKDREGSSLKKKCLPPSEAASDNHLKKPKHRDPEKAKLDKSKQGLDSFDTGKGAGDLLPKVKEKGSNNLKTPEGKVKTNL 380
32 -11.300[K] KOG4661 Hsp27-ERE-TATA-binding protein/Scaffold attachment factor (SAF-B)  ali follow..  5...........................................................................................................................................................................................................................................................................................................................................................................LSGLGDSGAAGPAALSSASSETGTRRLSDLRVIDLRADVRKRNVDSSGNKSVLMERLKKAIEDEGGNPDEIEITSEGNKKTSKRSSKGRKPEEEGVEDNGLEENSGDGQEDVETSLENLQDIDIMDISVLDEAEIDNGSVADCVEDDDADNLQESLSDSRELVEGEMKELPEQLQEHAIEDKETINNLDTSSSDFTILQEIEEPSLEPENEKILDILGETCKSEPVKEESSELEQPFAQDTSSVGPDRKLAEEEDLFDSAHPEEGDLDLASESTAHAQSSKADSLLAVVKREPAEQPGDGERTDCEPVGLEPAVEQSSAASELAEASSEELAEAPTEAPSPEARDSKEDGRKFDFDACNEVPPAPKESSTSEGADQKMSSPEDDSDTKRLSKEEKG 400
33 -11.200[S] COG5505 Predicted integral membrane protein  ali follow..  10  5.....ISSDDVWVLWGFIAVWAAVSIGLEQRFKWASAVSGAIIALAGAMVFTNVGV----PVESPVYDTVWSYVVPLAIPLLLFQINVR-QIFKESRRLLFIFLISSVGTVLGSILAFFLLKQHIPYLDKIGGMISASYIGGGVNFAAMAAKFE----------TPGEYVSATVVADNFMMALLFFILISINSAESYWKRKDISLKDIAFNAGAAFALVAVSMKVSGYFKSIFSHPLLTGTLGDQYLVLTSLTVLIIFLFPRFFERLNGSQELGTFL------------------------YLFFVVIGIPADLRLIVTNAPLILLFVFIIAISNLAVSLAAGKLF--------RVRLEEILLAVNATVGGPTTAAAMAIAKG........................................................................................................................................................................................................................................................................................................................................................................................ 362
34 -11.000[S] COG4906 Predicted membrane protein  ali follow..  11  5...............SLIITMSVLLGLNSAILADYLGVHIPLARQIFGFIAGYLLLKIFRTRLESFSEKIFLSVA-LSISVVMLM-GIFANFVYPLLGVEKPITLLPILLTFNVVTLGLLAVEQARTVPMIAKWDLFFALLPVWSLIGAYLFSHYGDNSGL-ALTPLVFLKSKNFNRTFAIWSIAISLMWSTVFG--SISTYDQYNTIASVNILGPVYSLILNMWIVPIFKII----------YPLVFSLVPVILLKAYERLLGNKIWAELSVLFFMFFFQFFVSRMMIVEVYLALLAYANPLFLILFLASLAVSHYGTAYLTMFALLTLPLIRVLENEQRISNKLIAVFWV---------VTLLWYAYVGGGFQFNNLVIIGYQTLLMLKDLFNPQYSQGLELIVAKMTFMREIAKLIFAQGLISIGVLTVLNRLIRGRKVKHLE......................................................................................................................................................................................................................................................................................................................... 470
35 -11.000[M] COG3064 Membrane protein involved in colicin uptake  ali follow..  14..................................................................................................................................................................................................................................................................................................................................................................................................................................AIIISAVLHIILFAVL------SSFDEHIEASAGGGGGSAIDAVMVDPGAVVQQYNRQQDQQASARRAEEERKKLQQQQAEELQQKQAAEQERLKQLEKERLAAQEQQKQAEEAAKLAQQQQQQAEEAAKAAADAKKKAEAEAAKAAADAKKKAEAEAVKAAADAKKKAEAEAAKAAADAKKKAEAEAAKAAAEAKKKAEAEAAKAAAEAKKKADAEAAKAAAEAKKKADAAAAKAAAEAKKKADAAAAKAAADAKKKAAAEKAAAAEGVDDLLGDLSSGKNAPKTGGGAKGNGQPSKDSGTSGANGGATGADISAYAKQIQVAIQSRLYDASLYQGKQ.. 348
36 -11.000[S] KOG2812 Uncharacterized conserved protein  ali follow..  75........................................................................................................................................................................................................................................................................................................................................................................................................................................................RSRSRSRERPSAPRGIPFASASSSVYYGSYSRPYGSDKPWPSLLDKEREESLRQKRLSERERIGELGAPEVWGLSPKNPEPDSDEHTPVEDEEPKKSTTSASTSEEEKKKKSSRSKERSKKRRKKKSSKRKHKKYSEDSDSDSDSETDSSDEDNKRRAKKAKKKEKKKKHRSKKYKKKRSKKSRKESSDSSSKESQEEFLENPWKDRTKAEEPSDLIGPEAPKTLTSQDDKPLNYGHALLPGEGAAMAEYVKAGKRIPRRGEIGLTSEEIASFECSGYVMSGSRHRRMEAVRLRKENQIYSADEKRALASFNQEERRKR 393
37 -11.000[A] KOG2253 U1 snRNP complex, subunit SNU71 and related PWI-motif proteins  ali follow..  1....................................................................................................................................................................................................................................................................................................................................................................................................................................MLSMCVCNPPSPPPFLFEKPYKLLCRASHWGIAPFFYSHSFVPSIRFISIILKLLPLLMNTNEIAIDAAAVAQGAEKELHDDREAKNRPEASKRSRRSRSSSNSSSESDSSSSRSSSYSSRSRSRTPQRSRTSKRRRSNSHASEDSDDAREKRAFKQMMLDKKQAYLARLKRWESRERQMSKRYEREERKEKDRKKTLQKEGKRLKLFLEDYDDEKDDPKYYTSSQFFQRKRDYEREREADQKDRMQEQQEIEELKRQIMEEAANDESINIEEEARKRHKLKEEEAMRKMRADSGSPNPHQPLGQSANGEKSSSEEESDSEKTDVKKEIKDEIKEEPID 339
38 -10.900[R] COG3180 Putative ammonia monooxygenase  ali follow..  10  27...................CLLALLSAVFAGVLEMIGIPAGLL---MGPMIAGALVGMNGGT--IRLPRQLFFCVQVVLAMMI---AASMSPDLLVTFSGNWLLFLAIILSVIGVSTLCGWTI-MGILPGTTAIWGSSAGAASTMLLMADAYGADARLVAFMQYLRVVF----------VASTATIVSHLWVSGVEAETATHWFAPIAGLPFFMTLAVGIASGILGKIL--------------------------------VPAGAFLVPFAIGSALNITGTLTIE---------LPQWLLALSFAMLGWNI--LGFTRAILAHARRALMPTIVSIVVLISFSGLLALLLIKVAGIDPLTAYLATSPG--GLDSIAVIAASSN------------------VDLPFVMALQTARLLIITLIGPALAR............................................................................................................................................................................................................................................................................................................................................ 356
39 -10.800[R] KOG2350 Zn-finger protein joined to JAZF1 (predicted suppressor)  ali follow..  624....................................................................................................................................................................................................................................................................................................................................................................................................................................MCSLFDYGIAAETVYKTVQKLQGLLSKYAAGQELMQRQREEQLKYWLDVGMHKKQEDPKTLKSPQKPAPPADQASTSSASTSGSGSGSSSMQPPKRMPAHLKRGSAASSPGVQSKGTENGTNGSNSSSSNSKNVAKKSADQPLSTLANTRERRSEYGQKRNVSGSRLAATPASKRKLSSKDVEQAADAPEVLTHSDNAVDVGIIDDECGGFGAVGVMNGVASPVANNSEMDTEAEVEAEPTATKAITIHCQQPVTTPVAAAATANERLPGVAPHRRGPRRADRREEELVASAPGYRCRPSMRGADAGAAAAAAAAPTHPHPHRPPPP............ 951
40 -10.700[R] COG0679 Predicted permeases  ali follow..  1..........................MLTFFIGDLLPI---IVIMLLGYFSGRRET------SEDQARAFNKLVLNYALPAALFVSITRANREMIFADTRLTLVSLVVIVGCFFFSWFGCYKFFKRTHAEAAVCALIAGSPTI-GFLGFAVLDPIYGDSVSTGLVVAIISI-------VNAITIPIGLYLLNPSSGADGKKNSNLSALISAAKEPVVWAPVLATILV------------------LVGVKIPAAWDPTFNLIAKANSVAVFAAGLTLAAHKFEFSAE-----------------------------------------IAYNTFLKLILMPLALLLVGMACHLNSEHLQMMVLAG---PPAFSGIIIASRFNVYTRTGTASLAVSVLG------------FVVTAPLWIYVSRLVS............................................................................................................................................................................................................................................................................................................................................. 314
41 -10.700[O] KOG2292 Oligosaccharyltransferase, STT3 subunit  ali follow..  1MNRTPKMLNSKSLITFAILLIAWLAGFSSRLFA--FNYRATAYMVQNGWYNFLNWFDERAWYPLGRIVGGTVYPGLMITSGGIHWLLHVLNIPV------HIRDICVFLAPIFSGLTSISTYLLTKELWSAGAGLFAASFIAIVPGYISRSVAG---------------------NEGIAIFALQFTYFLWVRSVKTGSVFWSAAAALSYFYMVSAWGGIPLHVFVLLIMGRYSPRLLTSYSTFYILGLLFSMQIIRTSEHMAALGVFVLLMAVATLRHLQSVLSRNEFRKLFIVGGLLVGVGVFVAVVVLTMLGV------------VAPWSGRFYSLWDTGYAKIHIPIIASVSEHQPTTWFSFFFDLHILVCAFPVGVWYCIKQINDERVFVVLAISAVYFAGVMVRLMLTLTPVVCMLAGVAFSGLLDVFLQEDSSKRMGTAISAATEVDEAEDSIEKKTLYDKAGKLKHRTKHDAQQDTGVSSNLKSIVILAVLMLLMMFAVHCTWVTSNAYSSPSIVLAFHNSQDGSRNILDDFREAYYWLSQNTADDARVMSWWDYGYQIAGMANRTTLVDNNTWNNSHIALVGKAMSSTEEKSYEIMTSLDVDYVLVIFGGVIGYSGDDINKFLWMVRIAEGEHPKDIKESDYFTDRGEFRVDAEGAPALLNFDLTYLEEAYTTEHWLVRIYRVKKPHEFNRPSLKTKERTIPPANFISRKNSKRRKGYIRNRPVVVKGKRTLK................. 774
42 -10.700[S] KOG4843 Uncharacterized conserved protein  ali follow..  211......................................................................................................................................................................................................................................................................................................................................................................................................................................................RNDGREMYGETKREIQGPKSDRDAKFERPGDDFSGKSNAGSYTRDTKFDRENQNYNEQKGEIKMEKEGHAHLAWKEQKDYHRGKRVAEGSTANVDPWVVSRGNPQGPTEVGPKDLSAPVEGSHLEGRETVGENKVDAKNEDRFKEKDKKRKELKHREWGDRDKDRNDRRVSVLVGSVMSEPKEIGREERESDRWERERMEQKDRERNKEKDKDHIKREPRTGAEKEISQNEKELGEASAKPSEQEYVAPEQKKQNEPDNCEKDERETKEKRRERDGDSEAERAEKRSRISEKESEDGCLEGEGATEREKDAFNYGVQQRKR 531
43 -10.700[A] KOG4849 mRNA cleavage factor I subunit/CPSF subunit  ali follow..  409.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PPPQFAQHGPRGPWPPPQGKPPGPFPDPQQMGPQLTEVEFEEVMSRNRTVSSSAIARAVSDAAAGEYSSAIETLVTAISLIKQSKVAHDERCKILISSLQDTLHGIEAKSYNRRERSRSRERSHRSRQRRERSTSRYRERSRERERDRDRERERDGGRSVRPRKSPEPVVAEAAEAPSSKRYYEDRERYRSSDRERRDRDRDRDRERERDRDRHFTNDGRGLPLDPSNFTSQNPGNIKTGRPKSAAVAGGSMEKPRGQSAWDIIDTDAHWIIKQQTTSIPAPPSSQ 694
44 -10.600[Z] KOG3809 Microtubule-binding protein MIP-T3  ali follow..  35...........................................................................................................................................................................................................................................................................................................................................................................................................................LHDIITEVIRMTGFMKGLYTDAEMKSDNVKDKDAKISFLQKAIDVVVMVSGEPLLAKPARIVAGHEPERTNELLQIIGKCCLNKLSSDDAVRRVLAGEKGEVKGRASLTSRSQELDNKNVREEESRVHKNTEDRGDAEIKERSTSRDRKQKEELKEDRKPREKDKDKEKAKENGGNRHREGERERAKARARPDNERQKDRGNRERDRDSERKKETERKSEGGKEKERLRDRDRERDRDKGKDRDRRRVKNGEHSWDLDREKNREHDKPEKKSASSGEMSKKLSDGTFKDSKAETETEISTRASKSLTTKTSKRRSKNSVEGRKEDNISAKSLDSIVSGINNEPNQETT 382
45 -10.600[A] KOG0113 U1 small nuclear ribonucleoprotein (RRM superfamily)  ali follow..  103..................................................................................................................................................................................................................................................................................................................................................................................................................................TLFIARINYDTSESKLRREFEFYGPIKKIVLIHDQESGKPKGYAFIEYEHERDMHAAYKHADGKKIDSKRVLVDVERARTVKGWLPRRLGGGLGGTRRGGNDVNIKHSGREDNERERERYRLEREREDREGPGRGGGSNGLDARPGRGFGAERRRSRSRERRDRERDRGRGAVASNGRSRSRSRERRKRRAGSRERYDEFDRRDRRDRERERDRDREREKKKKRSKSRERESSRERRERKRERRDRERGTGSGGDVKERKPDFRDMDVIKIKEEPVDDGYPTFDYQNATIKREIDDEDEEKYRPPPAHHNMFSVPPPPILGRGNASTNPNPDNGQQSSGDP 443
46 -10.200[S] COG2035 Predicted membrane protein  ali follow..  1.....................................MLSWLARVIKGIVIA--------------LGFILPGISVLAAILGIYERMIGFLAHPFKDFKENVLYFVAIGMLLGIGLFSYPIEYLLENYQVFVLWSFAGAIIGTVPSLLKESTRESDRDKID-----------------LWTTFIISGLGLYALNFVVGTLSASFLNFVLAGALLALGV-LVPGLSPSNLL----------------LILGLYAPMLTGFKTFDFLGTFFPIGIGAGAT----------LIVFSKLIDYALNRVYHFIIGIVLPNAGNAESIQYTGLSLVGYVIIAFFFALGIWLGIWMSQL........................................................................................................................................................................................................................................................................................................................................................................................................................ 275
47 -10.200[S] KOG3683 Uncharacterized conserved protein  ali follow..  12  3........................................................................................................................................................................................................................................................................................................................................................................RLQMT--GHISCTAVEF-------------SYMSKISLNTPPGTKVKLSGIVDIKNGFLLLNNTTVLGGEVEHLIEKWELQRSLSKHNRSNIGTEGGPPPFVPFGQKCVSHVQVDSRELDRRKTLQVTMPVKPTNDNDEFEKQRTAAIAEVAKSKETKTFGGGGGGARSNLNMNAAGNRNREVLQKEKSTKSEGKHEGVYRELVDEKALKHITEMGFSKEASRQALMDNGNNLEAALNVLLTSNKQKPVMGPPLRGRGKGRGRIRSEDEEDLGNARPSAPSTLFDFLESKMGTLNVEEPKSQPQQLHQGQYRSSNTEQNGVKDNNHLRHPPRNDTRQPRNEKPPRFQRDSQNSKSVLEGSGLPRNRGSERPSTSSVSEVWAEDRIKCDRPYSRYDRTKD 389
48 -9.930[R] KOG2563 Permease of the major facilitator superfamily  ali follow..  72YVNSFYGESSAAWLSMVYMMCTIPVGMFAMWAGREWGLRTAVLIAGWANGIGAVIRVISSLDFVPQDLRFICMTGQGIAAIFIMFLPTKVAGSWFPDTQRAIATSIGLGVLMANLISPAIVLNIFTCVPSLIAMLIATFGVNRSEPKIPPTFSASKPQMDFVSGMKSCFSSKQGGGIGMFNCLYTVMLELLCPSGYSNFFSGVCAALMI-------VGGVFGAAASSIFVDRTKLYEETLKIALGAAVIFGLIFLQLTLHQGY---GVTCLLFGVLGLECTFPVSEATSTGLIVLSGQIQSVIYVFIMKNFARPLQPDRMHIQVTMSIMIFSLLATLLVLTLVVLF............................................................................................................................................................................................................................................................................................................................................................................................................................. 462
49 -9.920[U] KOG3799 Rab3 effector RIM1 and related proteins, contain Rab3a binding domain  ali follow..  172......................................................................................................................................................................................................................................................................................................................................................................................................................................................QRRAEPPDKMNTPNYQNNQQPRGMGMQPNHNQTQQNFMNQNQNSNQHPNQNHNQNQMQNPHQNQNHVQNNHQGANNHQQNNRRAMQQQPMSQNQANQINQMNQNQNQQQSHNQNMTQNQRNQTGPQNQQRTNDSRTMKQTPQQQPSQYQNNVGAAHQHHNQHGQQEQHHQQMNEQRTDNNRMRENTNGQGGMFNRQPSLEQTTPMNKYNHVEDDGMNQRPTFYTGNSENDQRQFDGQMQQGSQQNNQNQNQNNRNLRKNTVSRVTEEDYASSSNFESKKQRNNSSQSQSNTQGVRACPSTDDHLNRVKNRLHRQLRSMSSS 492
50 -9.840[S] COG3274 Uncharacterized protein conserved in bacteria  ali follow..  11  1MTNKIDWIDNLRAVACIMVVMIHSTTDIANVLNSASRACVPLFFMISGYLF------------FGEKSAQKKHFMRIGLCLLFYSVIALI------------YISTLTPIDGWASLRNILQKPVFYHLWFFYAIIVVYLVSPL---------------------IKVKPVSGRYLA--ILILLLAVVANPQTSKFSLDDFRLLPANLYIYGDTFYYLLYALLGRAMGMLETQGRMISWGAALLFVVSVICIAISTEKQTRINGSFA-PLVFIAAVSL--------KNCLNQHIAWLSGLARHSLAIYGFHALIIHFIRTHHYDFTAYPVLDILYVFALTLGLSTLLSMG.......................................................................................................................................................................................................................................................................................................................................................................................................................... 319
51 -9.830[Y] KOG2992 Nucleolar GTPase/ATPase p130  ali follow..  100.........................................................................................................................................................................................................................................................................................................................................................................................................................................................AASSTSEDSDSEEEKKPAAKATPAKAVGKKAKSSSEDSSSEEEAPKKAAPVKAPPAKAAPAKKVESSSEDSSSEEEPAKPAVKATTTKVAPAKKADSSSEESSSDEETKPAAKPVAKAAPAKKAASSSEESDSDDEPAAKKPAVQPAAKPAPKAAASSSEDSSSEEEVKPAAKSAAKLAPAKKGASSSDDSSSEDEAPKKAATLAKPISKAAPTKKADSSTEDSSSEDDAPKKVAPAKATPAKAIPAKKAASSDDSSSEEEAPKKAAPAKATPAKATPAKKAASSDDSSSEEEAPKKAAAPAKATPAKKAKSSSED.. 415
52 -9.760[R] KOG0151 Predicted splicing regulator, contains RRM, SWAP and RPR domains  ali follow..  429.............................................................................................................................................................TDSQRDEFEDMLRALTLERSQIR-----AMGFALDNAEAAGEVVEVLTESLTLK---------------------------ETSIPTKVARL------MLVSDIIHNSS------ARVKNASAYRTKFEATLPDIMESFNDLYHS-----VHGRITAEALRVI-------------PESKYSSYVVLYPLKFCSHSYFVQERLKVLQVW--INGLRATFLRSRNFGVTSFHSICGDAPDIEKKGLIGNMNDAD---------------------KINQDAALAMGEGAARQELMNRPISELERRCRHNGLSLLGGREMMVARLVCLKDAEKQRGYEVVDENAKYRQGHSTWEEVNIEPKRMKTSYDKVETEEPVDLASTIPIPQPELKAFVKKEKIDLILPTSRWAREDDETDDEQKKSYSSGSDNAGGITFKTDEEDLKADPSVRVQPENEIDVEQRQKLRHIEIALIEYRESLEEQGMKNSEEIERKVAIHRKRLEADGLSGNQRVLPEKREKREDSRDSSRKRNRSESQNRSQSPPQKSLTRERVRDHDLDKDRHRDRDRQQHDLDKDRKRRAKSSSRERDDHDRSRERDRDWRRRGMR 957
53 -9.750[M] COG1807 4-amino-4-deoxy-L-arabinose transferase and related glycosyltransferases of PMT family  ali follow..  1.....MKSVRYLIGLFAFIACYYLLPISTRLLDETRYAEISREMLASGDWIVPH----LLGLRYFEKPIAGYWI--NSIGQWLF--GAN------------GVRAVIFATLLTAALVTWFTLRLWRDLALLATVIYLSLFAVLDPFIAFWLVAGMCS-------FWLAMQAQTWKGKSAGFLLLGITCGMG----------------VMTKGFLALAVPVLS--VLPWVATQKRWKDLFIYGWLAVISCVLTVLPWGLAIAQREPNFWHYFFWVEHIQRFALDDAQHRAPFWYYVPVIIAGSLVYLLSWTIMPLLFFSVAKGKLPTYILSCFASLAMLMAHYALLAAKNNPLALRINGWINIAFGVTGIIATFVVSPWGPMNTPVWQTFESYKVFCAWSIFSLWAFFGEKTWPFAALCPLGLALLVGFSIPDRVMEGKHPQFFVEMTQESLQPSR................................................................................................................................................................................................................................................................................................................ 450
54 -9.660[R] COG1287 Uncharacterized membrane protein, required for N-linked glycosylation  ali follow..  22...........IPLKVLILICIAVASVSSRLFS--FNFRASKILVEQGFYNFLNWFDERSWYPLGRVAGGTLYPGLMVTSGIIFKVLHLLRINV------NIRDVCVLLAPAFSGITAIATYYLARELKSDACGLLAAAFMGIAPGYTSRSVAG---------------------NEAIAITLLMSTFALWIKAVKSG--------SSFWGACTGLLYFYMVGYFVLLLMGRYTSKLYIAYTTYYVIGTLASMQVFQPVSTSEHMSALGVFGLLQLFAFYNYVKGLVSSKQFQILIRFALVCLVGLATVVLFALSSTGVIAPWTGRFYSLWDTNYAKIHIPIIASVS---------EHQPPTWSSLFFDLQFLIWLLPVGVYLCFKELRNEHVFIIISVLGTYFCGVMVRLVLTLTPCVCIAAAVAISTLLDTYMGPEVEEDKVSEEAASAKSKNKKGIFS.......................................................................................................................................................................................................................................................................................................... 462
55 -9.650[G] COG0738 Fucose permease  ali follow..  10  23.....FALTSLTLLFFMSGFITCLNDILIPHLKNVFQLNYTQSMLIGAYFIVSLPAGQL-VKRISYKCGIVVGLIVAAIGCALFIPAASYRVYALF-----LGALFVLASGVTILQVAANPYVTILGLTLTQAF-LGTTVA---PVFGAVLIVQEDEPALSDKKEGSAWQYRHLV--GAIGIFVYVGAEVSVGSFLVNFLSDPTVAGLSETDAAHHVAYFWGGAMVGRFIGSAAMRYIDDGKALAFNAFVAIILLFITVATTGHIAMWSVLAIGLFNSIMFPTIFSLALHGLGSHTSQGSGILCLAIVGGAIVPLIQGALADAIGIHLAFLMPIICYAYIAF................................................................................................................................................................................................................................................................................................................................................................................................................................. 404
56 -9.610[R] KOG3700 Predicted acyltransferase  ali follow..  240......QFKCGVEDFHGILALSKCQGDIQNEAEGQVTLNCIRTISTVWVILGHCAAMLILICT-FTKTYMGALLVNAYFAVDTF-SAFLLSFLWFKQLQKQRKALLSPAYYIAILFVTFVYIRMLRD--WLNLLYIENIVDTKNICYVISWYLATDLQLYLMSPILLLSFAIGGAVFGLFASVVALVASTAFNYNENERRYDVWNYYNPLIRCQIYIMGLVLGY----FMRKVPKININPWVDRIMWVLSLGSM------------VFVVLVIQDYSSGDGWTPVQTALYRSYSKTALAKLILESVSIIIQNKKNIFINYKYFSLFFFIFFNIYNCFSRVLWGFAMSWIVISTYYRKGLIRDFMSLSFWTPLARLSFCAYLVHWMVLGYFFGRNHSELYFSTLSYFFLDTVIPVTALSFVIAIFWSSMFEIPFAKIEGLLLGRSGTPKANGNLPKVMIIPLEIPKAGEVNIK............................................................................................................................................................................................................................................................................................... 764
57 -9.600[S] COG3859 Predicted membrane protein  ali follow..  10  1....................................................................................................................................................MCASKRSFFMSNSKFNVRLLTEI------AFMAALAFIISLIPNTVYGWIIVEIACIPILILSFRRGLTAGLVGGLIWG-ILSMITGHAYILTLSQAFLEYLIAPVSLGIAGLFRQK--LVPVLLGTFVA--------VLLKYFFHFIAGIIFWSQYAWKGWGAVAYSLAVNGISAILTAIAAFVILIIFVKKFPKLF............................................................................................................................................................................................................................................................................................................................................................................................................................. 186
58 -9.600[R] KOG4520 Predicted coiled-coil protein  ali follow..  52..............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................AKGRAPCAGPSREEELAAVREAEREALLAALGYKNVKKQPTGLSKEDFAEVCKREGGDPEEKGVDRLLGLGSASGSVGRVAMSREDKEAAKLGLSVFTHHRVESGGPGTSAASARRKPRAEDQTESSCESHRKS---KKEKKKKKKRKHKKEKKKKDKEHRRPAEATSSPTSPERPRHHHHDSDSNSPCCKRRKRGHSGDRRSPSRRWHDRGSEA.. 263
59 -9.540[O] KOG0314 Predicted E3 ubiquitin ligase  ali follow..  483...............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PNIPPPYRDLAEMGNRMNLQHPIMGREEFEAKKTEMKRKRENEIRRSEGGNVVRDSEKSRIMNNSAVTSSPVKPKSRQGPPPPISSDYDRRRRSDRSSPERQSSRRFTSPPRSSSRKSERDRHHDLDSEHDRRRDRPRETDRKHRKRSEKSSSDPTVEIDDNNKSNVFTRISFPEESSGKQRKTSKSSPAPPESSVAPVSSGRRHHSRREREMVEYDSSDDEDRHFKRKPSRYKRSPSVAPSDAGDEHFRHSKRSKGERARA.. 744
60 -9.530[Q] COG4664 TRAP-type mannitol/chloroaromatic compound transport system, large permease component  ali follow..  11  2.....IEFVAENLAPIMFVSLIVFLLL---------GYPVAFSLAANGLLFFIIGVELAPLSDSINLSWPLLNALPLAIPFFTFMGIVLERSGMAEDLLDTIGQLFVRGGLAYAVIFVGALLAATTGVVAASVIAMGLISLPIRRIASGVIAASGTLAQIIPPSLVLIVLADGALIPGLVLTGLYMGYILLMARTLGSGVASLAIALLVACAIAYAAHVYLSPTQGENAALSRLAQQVIIVLIPPLALIFLVLGTIFLGIATPTEGGAMGAVGALVMAAGKGRLNMEVVRAALASTTRLSAFVLFILIGARVFSLTFYGVNGHLWVEHIAVNVLVFFLAFFLDFFELAFIIVPLLAPAADKLGIDWFGVTSFMHFGFALFYLRSVAARVPYLDRVTGKMMQPVTTGQIYWGAVPFVCIQVVMVALT............................................................................................................................................................................................................................................................................................................................................. 508
61 -9.460[C] COG3493 Na+/citrate symporter  ali follow..  12  20....RFKIFGMPLPLYAFALITLLLSHFYNAIPTDL-VGGFALMFVMGAIFGEIGKRLPIFNKYIGGAPVMIFLVNLFIAVLITGAILSVNRKLLLKSLLGYIPTILAGIVGASLFGIVIG--LCFGIPVDRIMMLYVL-----PIMG------------------------GGNGAG-AVPLSEIYHSVTGRSREE----------YYSTAIAILTIANIFAIIFAALLDMIDEKAGQITHRETAVGMVLSTTCFLLAYVIHYFAWMVLIVAALNASGLCSPEIKAGAKRLSDFFSKQLLWVLMVGVGVCYT--DLQEIIDALTFANVVIAAIIVVGAVVGAAIGGLIGFYPIESSITAGLCMANRGGSGDLEVLSACNRMNLISYAQISSRLGGGIVLVIASIV................................................................................................................................................................................................................................................................................................................................................................. 441
62 -9.430[E] COG1296 Predicted branched-chain amino acid permease (azaleucine resistance)  ali follow..  11  14..................................GETLTVGLGLIPLGLAFGLLMVQT------------FAWWWTPIFSFVIYAGSMEF----------------------------LAIGMVTAGIGPFSAAVAGFMVNFRHIFYGLTFPRHRIKSGAGRAYSTYALTDES------------YAIVSARPPGDISGTRVLTVQILCQALVIPGIIGALVGQVLPDDLKGMD------------FALTALFVVLAWEAFKNNKDYSLPLFAVVL---------ALVSGFVAPEQMLVIALTTYFLILLLR............................................................................................................................................................................................................................................................................................................................................................................................................................................................... 220
63 -9.400[S] COG4984 Predicted membrane protein  ali follow..  10  217YYYKERRFDFLNLIVLFFYLVVSICTKVLLSSGEDFDIFLVTILAFGGTIGAIITLIKWFKWHNPTASRVTWHIYPLFILLIIFCTGLLLITLFFSFGLEDEQDLIYPSILFLIIALVM----HFNQKEKADWFDIAIDMFMATGFILYFIFFLFDGENDLYLALMAILSVSNWLR---FLIASLFIIAFLVYIGFFDLRWYAYYEEHLGQFVLSAQQWIILGGLLLYYFFSLSEER---PYTIKLLPIAWAMLLVGLAMNLDINDWFHVITGYF-------FTALTSDTWLIKSLHLLISITPIIFF--VLISRRFELTKFLYASVLLTLLALCLGFIAVNETLACISLLLLAYLSVSRVLFLALLGVIMNLSYYYYLLSI---------------------PLLHKSFLLMGVGIVLALVTFVLLRYNKAPQATLQAESHNT........................................................................................................................................................................................................................................................................................................................... 649
64 -9.390[A] KOG1295 Nonsense-mediated decay protein Upf3  ali follow..  20.........................................................................................................................................................................................................................................................................................................................................................................VFVDHKGVEYMAIVEYAPF--QCFLKNKARNDDSKVNTIESEPHYQE----------------FIKRLAQEREEASRMGDVKIDFNFERRTEEKVKSTPLLQYLANKKEKRREEARRRNEEKRKQREEQKLLRLAAQSDASKLKEAEGGGGGGDTKKPAKKDVKDPQSSGSQANDAKASRSKRRTERDQRRREEHEQRKLVKRDKKKDDGQGKQDKQDKQDKGKPSSGKQNKNSKSMDIVILKKANKPESNESLDVPSTSNAAEASKEKPATENTETPEAAVKVFTPAARGGRKEKRTGADKQPAGSAHETAEEAIKAAQFRASEERRIRNKVGLTYYPPRHFTNPLDVYRIDHRLPFTSPKPEFVHQMSCPKVQAAKMARMERLPWWRRRLRRGTNA 399
65 -9.340[P] COG1055 Na+/H+ antiporter NhaD and related arsenite permeases  ali follow..  10  4................MILAVFIFLLTLVLVIWQPKNLSIGWSACGGAVLA--LIAGVVNFHDVLTVTGIVWNATLAFVAIILISLILDAALHMAKAAKGYGVRMFVYVSLLGAIVAALFAN--------------GAALILTPIVLAMVRALHFNEKLVFP----FIIASGFIADTTSLPFVVSNLVNIVSADYFHITFIDYASRMVVPYLFSLLASIIVLYLFFRKSIPKRYDLTEVKKPVESWYILGLLLIGYFASEFFSIPVSVVAGSIAIIFLIAAQKSPAVHTKKVVKEAPW----IVFFSIGMYVVVYGVRNAGLTDVLSDVIQAAADQGLFAGTIGMGFIAAILSSIMN-------------NLPTVMIDALAIAGTDTHGMMREALIYANVIGSDLGPKITPIGSLATLLWLHVLSHKGMKISWGT.................................................................................................................................................................................................................................................................................................................................... 404
66 -9.290[M] COG1346 Putative effector of murein hydrolase  ali follow..  2.......MANIWWSLPLTLIVFFAARKLAARYKFPLLNPLLVAMVVIIPFLMLTGISYDSYFKGSEVLNDLLQPAVVALAYPLYE-----QLHQIRARWKSIITICFIGSVVAMVTGTSVALLMGASPEIAASILPKSVTTP----IAMAVGGSIGGI----PAISAVCVIFVGILGAVFGHTLLNAMRI--------------------KAARGLAMGTASALGTARCAELDYQEGAFSSLALVLCGIITSLIAPFLFPII-------LAVMG..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 231
67 -9.240[S] COG4763 Predicted membrane protein  ali follow..  14  1...............................MKQKEWINQIKGLCICLVVIYHSVITFYPHMTTFQHIYFNLYLAPFRMPVFFFISGYLIRRYIDSVPWGNCLDKRIWNIFWVLAL-----------WGVVQWLALSALNQWLAPERDLSNASNAAYADSTGEFLHGMITASTSL-------WYLYALIVY-----------FVVCKIFSRLALPLFALFVL---------------------LSVAVNFVPTPWWGMNSVI----NLPYYSLGAWF--------GATIMTCVKEVPLRRHLLMASLLAALAVGAWLFTISLLLSLVSIVVIMKLFYQYEQR-------------FGMRSTSLLNVIG-SNTIAIYTTHRILVEIFSLTLLAQMNAARWSPQVELTLLLVYPFVSLFICTVAGLLVRKLS......................................................................................................................................................................................................................................................................................................................................... 335
68 -9.220[S] KOG2654 Uncharacterized conserved protein  ali follow..  53........................................................................................................................................................................................................................................................................................................................................................................................................................................................RDIGSDEEREEIEVLKQSVKKAKVVHGFKQTFAEVDAPKVIKPEPLSPDNSPPRGKRQRHDSDNSPPRPSRKRNDSDNSPPRPSRNRHDSDKDNSPPRRRRHDSDNSPPRPSRKIREESPSARNRRSPPRTRRDRHDSDNSPPRNRSRRDSDNSPPRRRPSSPARRRKDDDLSPPRKSRKIEEPKKIKKEEPDSDTETSGRTLEGKRSGLQSARDLKEESDKLRAKNSKMFEEMDTSVSGRFADTVYRQKQTKKKGKDSEEDQAKKERETKKTEELKEKYKSWNKGVAQIEDRRAQLEEMARVAAEPMARARDDDAMNA 371
69 -9.180[GOU] COG5070 Nucleotide-sugar transporter  ali follow..  23............ISILSYCGSSILMTVTNKFVVNLKDFNMNFVMLFVQSLVCTITLIILRILGYAKFRSLNKTDAKNWFPISFLLVLLAVPIYTIFKNLTIILIAYGELSSFLLMVLSSVV-ATWGDQQAVAAKAASLAEGAAGAVMFTNCITSALFVLIMRKRIKLT-DFDTMFYNNVLALPILLLFSFCVEDWSSVNLTNNFSNDSLTAMIISGVASVGISYCSGWCVRVTSSTTYMVGALNKLPIALSGLIFFD-RNFLSILSIFIGFLSGIIYAVAKQKKQQAQPLR.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 336
70 -9.140[G] COG3936 Protein involved in polysaccharide intercellular adhesin (PIA) synthesis/biofilm formation  ali follow..  1.......................................................MPTLTFKLIFSYRIFIYLLVFVLFPILLFYNSSLLGVKSYKKSTDCIKGLSILVIILHHISLRMQPVGFMGIYTCLGHLAVSMFLFFSGYGLMVSKLKKKNYFKGFSKRLSKVY---------LPFVIINAITIILTSLIFGTKFNLKDIIFYLSGLSLIDSTQWFVIAILVFYLCFYVCFKFLSTNLAQHILLFLTFVYFFAMIFMGFREWAFCFPLGVYAAINYDALTKFLEKHYVKTLIIALIAFTFFFFLAHMLPSAIMPLYQTIASIIFVYLVLLFLFKFRL-----------------SSKPLLFLG-----NIAYEIYLVHMK----------ILVAFFSFIGARGSYIVYLYLILVIIVAFCFNKLFNLNKNKKVKLT.............................................................................................................................................................................................................................................................................................................................. 356
71 -9.130[O] COG2370 Hydrogenase/urease accessory protein  ali follow..  13  1MAGSPRSRCERQQFQEGIMLKRLSLAAAALGLTTLPAFAHLNPEEHGSFMAG-----------------VSHPFFGADHILAMVAVGI-WASQIASARNDRKALWIVPAAFVGTMAVGFLMAVYGVELPFVEPAILASVI-----GLGLLVA----MAARLPTAAAAAVVGAFALFHGHAH------------------------GELGSAGALQFGIGFMIATAILHLAGIALGLGIARFGSAASRTVGALTAIAGLSLAFGG............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 214
72 -9.120[S] KOG3100 Uncharacterized conserved protein  ali follow..  1..................................................................................................................................................................................................................................................................................................................................................................................................................................MVVTR-----------SARAKASIQAASAESSGQKSFAANGIQAHPESSTGSDARTTDESQTTGKQSLIPRTPKARKSKSRTTGSLPKGTEPSTDGETSEAESNYSVSEHHDTILRVTRRRQILIACSPVSSVRKKPKVTPTKESYTEEIVSEAESHVSGISRIVLPTEKTTGARRSKAKSLTDPSQESHTEAISDAETSSSDISFSGIATRRTRSMQRKLKAQTEKKDSKIVPGNEKQIVGTPVNSEDSDTRQTSHLQARSLSEINKPNFYNNDFDDDFSHRSSENILTVHEQANVESLKETKQNCKDLDEDANGITDEGKEINEKSSQLKNLSELQDTS 330
73 -9.120[GOU] KOG1444 Nucleotide-sugar transporter VRG4/SQV-7  ali follow..  7KSLQYLAVPIYTIFKNLTIILIAYGEVLFFGGKVTSMELTSFIMMVLSSVVATWG---QQAIAIKASSLEDLDQELVESTIFVLNPGYLW-------------------------------------------MFTNCISSALFVLIMRKRIRLTNFK-----DYDTMF-----YNNVLALPLL-LVFSFIMEDWSTKNLSVNLSADSLAAMVISGLMSVGISYCSGWCVRVTSSTTYMVGALNKLPIALAGLVFFD-KNFLSFFSIFLGFLSGLLYAVAKQKKIQQQKVL.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 243
74 -9.100[R] COG1266 Predicted metal-dependent membrane protease  ali follow..  3......................................................................................................IRVITMGLPMNPLTAFTLAFLLYITHGFYLSGFIRPFQRRFGEIEGYWIAMS-------------------------IFTVAFAVLITLLCPELYFVSWSFPIDYFLLFLSLSFLAFIPTVFELRKPESPEISDEGVNKSMGFKDVALLQVISAALPEELVFRYVFSLIALSIFFG---------IGHKFSHPNRNWNVLISNALIGFVLGLAYLYTKSLPVVMAIHWLDDMVPWAFIKYERAVLPLVLLWDKLVSVIEYLRGIYSNEGLVLGSGIAIIM......................................................................................................................................................................................................................................................................................................................................................................................... 273
75 -9.080[S] COG5427 Uncharacterized membrane protein  ali follow..  11  1.....MEFGVVARWWVFFGVLLVAGLPVASRLLPDAPDRGASVAMPLSLVVVTLATLWVGQVAYGQLVVGGVFVAVLAAAAWLARGGVEIPRKPL---------LEVVGVFTVAFVFLIVVRAWADDFGLLQALDRAGQLPPRDMWFAGERVVYYYGGQLMASIGAHLTDTAPRFAYEPALAGVYAMGCTAAYGLASTIAAGVAVPAAAAAVVVTRPRRVRAGVLGAFAFGFASNLGPVIRLLAARVDVVFPLFAYLNGD-LHAHMVVLFVAVAVGVAYYRTPARQRRRRWA------LLWGGFPVAGAAILTVNTWSLPTVFGVAALAVALVLLAVGVAAVGGVLAVVIAWPFVQNVLLAGAGALVFVHGLFLAAFGAYFVSRVATSVAGWVVAAAAAGAAVAVAVAVGPVVGGVGITAVVLVGP............................................................................................................................................................................................................................................................................................................................................. 533

FFAS is supported by the NIH grant R01-GM087218-01
1 4 7 6 0 4   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Mayya Sedova, Mallika Iyer, Zhanwen Li, Lukasz Jaroszewski, Kai W Post, Thomas Hrabe, Eduard Porta-Pardo, Adam Godzik Cancer3D 2.0:: interactive analysis of 3D patterns of cancer mutations in cancer subsets. Nucleic Acids Research, gky1098 2018; Published on November 8 2018.

Friedberg I, Nika K, Tautz L, Saito K, Cerignoli F, Friedberg I, Godzik A, Mustelin T. Identification and characterization of DUSP27, a novel dual-specific protein phosphatase. FEBS Lett. 2007 May 29;581(13):2527-33. Epub 2007 Apr 30.